352 related articles for article (PubMed ID: 33508126)
1. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification.
Maire CL; Fuh MM; Kaulich K; Fita KD; Stevic I; Heiland DH; Welsh JA; Jones JC; Görgens A; Ricklefs T; Dührsen L; Sauvigny T; Joosse SA; Reifenberger G; Pantel K; Glatzel M; Miklosi AG; Felce JH; Caselli M; Pereno V; Reimer R; Schlüter H; Westphal M; Schüller U; Lamszus K; Ricklefs FL
Neuro Oncol; 2021 Jul; 23(7):1087-1099. PubMed ID: 33508126
[TBL] [Abstract][Full Text] [Related]
2. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
[TBL] [Abstract][Full Text] [Related]
3. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
6. Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Reátegui E; van der Vos KE; Lai CP; Zeinali M; Atai NA; Aldikacti B; Floyd FP; H Khankhel A; Thapar V; Hochberg FH; Sequist LV; Nahed BV; S Carter B; Toner M; Balaj L; T Ting D; Breakefield XO; Stott SL
Nat Commun; 2018 Jan; 9(1):175. PubMed ID: 29330365
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
Hallal S; Azimi A; Wei H; Ho N; Lee MYT; Sim HW; Sy J; Shivalingam B; Buckland ME; Alexander-Kaufman KL
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635403
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
9. Extracellular Vesicles from Neurosurgical Aspirates Identifies Chaperonin Containing TCP1 Subunit 6A as a Potential Glioblastoma Biomarker with Prognostic Significance.
Hallal S; Russell BP; Wei H; Lee MYT; Toon CW; Sy J; Shivalingam B; Buckland ME; Kaufman KL
Proteomics; 2019 Jan; 19(1-2):e1800157. PubMed ID: 30451371
[TBL] [Abstract][Full Text] [Related]
10. Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics.
Indira Chandran V; Welinder C; Gonçalves de Oliveira K; Cerezo-Magaña M; Månsson AS; Johansson MC; Marko-Varga G; Belting M
J Neurooncol; 2019 Sep; 144(3):477-488. PubMed ID: 31414377
[TBL] [Abstract][Full Text] [Related]
11. Gliomatosis cerebri: no evidence for a separate brain tumor entity.
Herrlinger U; Jones DTW; Glas M; Hattingen E; Gramatzki D; Stuplich M; Felsberg J; Bähr O; Gielen GH; Simon M; Wiewrodt D; Schabet M; Hovestadt V; Capper D; Steinbach JP; von Deimling A; Lichter P; Pfister SM; Weller M; Reifenberger G
Acta Neuropathol; 2016 Feb; 131(2):309-319. PubMed ID: 26493382
[TBL] [Abstract][Full Text] [Related]
12. ExRNA in Biofluids as Biomarkers for Brain Tumors.
Rennert RC; Hochberg FH; Carter BS
Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
[TBL] [Abstract][Full Text] [Related]
13. High density DNA methylation array is a reliable alternative for PCR-based analysis of the MGMT promoter methylation status in glioblastoma.
Braczynski AK; Capper D; Jones DTW; Schittenhelm J; Stichel D; von Deimling A; Harter PN; Mittelbronn M
Pathol Res Pract; 2020 Jan; 216(1):152728. PubMed ID: 31784096
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicles in Brain Tumor Progression.
D'Asti E; Chennakrishnaiah S; Lee TH; Rak J
Cell Mol Neurobiol; 2016 Apr; 36(3):383-407. PubMed ID: 26993504
[TBL] [Abstract][Full Text] [Related]
15. Glioma-Derived miRNA-Containing Extracellular Vesicles Induce Angiogenesis by Reprogramming Brain Endothelial Cells.
Lucero R; Zappulli V; Sammarco A; Murillo OD; Cheah PS; Srinivasan S; Tai E; Ting DT; Wei Z; Roth ME; Laurent LC; Krichevsky AM; Breakefield XO; Milosavljevic A
Cell Rep; 2020 Feb; 30(7):2065-2074.e4. PubMed ID: 32075753
[TBL] [Abstract][Full Text] [Related]
16. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain.
van der Vos KE; Abels ER; Zhang X; Lai C; Carrizosa E; Oakley D; Prabhakar S; Mardini O; Crommentuijn MH; Skog J; Krichevsky AM; Stemmer-Rachamimov A; Mempel TR; El Khoury J; Hickman SE; Breakefield XO
Neuro Oncol; 2016 Jan; 18(1):58-69. PubMed ID: 26433199
[TBL] [Abstract][Full Text] [Related]
17. A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform.
Lewis J; Alattar AA; Akers J; Carter BS; Heller M; Chen CC
Sci Rep; 2019 Jul; 9(1):10279. PubMed ID: 31311947
[TBL] [Abstract][Full Text] [Related]
18. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
[TBL] [Abstract][Full Text] [Related]
19. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
[No Abstract] [Full Text] [Related]
20. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
